Evaluation and applicability of Alere iCup DX 14 for rapid postmortem urine drug screening at autopsy
- 6 October 2020
- journal article
- research article
- Published by Wiley in Journal of Forensic Sciences
- Vol. 66 (1) , 375-382
Abstract
Performing point‐of‐care urine drug screen testing at autopsy by a forensic pathologist may provide an early indication of the presence of analytes of interest during autopsy. An evaluation for the screening of 14 classes of common drugs of abuse in postmortem urine by the point‐of‐care screening device, Alere iCup DX 14, is presented. One hundred ninety postmortem urine samples were screened with the iCup occurring at autopsy by the forensic pathologist. Positive and negative results obtained from the screening kit were evaluated against confirmatory test results obtained using routine forensic toxicology analyses that employed LC‐MS/MS and GC‐MS to detect a combination of over 85 common drugs of abuse and medications. Sensitivity for each respective iCup drug class ranged from 66% (buprenorphine) to 100% (methadone, tricyclic antidepressants). Specificity for each respective iCup drug class ranged from 89% (benzodiazepines) to 100% (amphetamines, barbiturates, buprenorphine, 3,4‐methylenedioxymethamphetamine, methadone). Positive predictive values ranged from 44% (benzodiazepines) to 100% (amphetamines, barbiturates, buprenorphine, methylenedioxymethamphetamine, methadone), while negative predictive values ranged from 96% (methamphetamine) to 100% (barbiturates, methadone, tricyclic antidepressants). A high false‐positive rate was yielded by the benzodiazepine class. The lack of fentanyl screening in the point‐of‐care device is a significant limitation considering its prolific prevalence in forensic casework. The results obtained in the study should be acknowledged when considering the use of the Alere iCup DX 14 in the context of postmortem casework to help indicate potential drug use contemporaneously with autopsy and when requiring such preliminary results prior to the release of a final forensic toxicology report.Keywords
This publication has 11 references indexed in Scilit:
- Method Consolidation to Improve Scope and Efficiency in Postmortem ToxicologyJournal of Analytical Toxicology, 2020
- Point of Care Devices for Drugs of Abuse Testing: Limitations and Pitfalls2019
- Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive reviewNeuropharmacology, 2018
- Point-of-Care Testing for Infectious Diseases: Past, Present, and FutureJournal of Clinical Microbiology, 2017
- Screening tests: a review with examplesInhalation Toxicology, 2014
- A Review of the Methods, Interpretation, and Limitations of the Urine Drug ScreenOrthopedics, 2011
- Drug-of-Abuse Testing at the Point of CareClinics In Laboratory Medicine, 2009
- Understanding diagnostic tests 1: sensitivity, specificity and predictive valuesActa Paediatrica, 2007
- Toxicology and Drugs of Abuse Testing at the Point of CareClinics In Laboratory Medicine, 2001
- Application of the Novel lmmunoassay TRIAGE™ to a Rapid Detection of Antemortem Drug AbuseJournal of Analytical Toxicology, 1994